Germany tells some patients to stop using Celebrex

	Tweet

Germany’s drug regulator on Monday told patients with cardiovascular risks to stop using Pfizer’s arthritis drug Celebrex after new data emerged linking it to an elevated risk of heart attacks.

The drug regulator said in a statement it was not “justifiable” to treat patients with a history of heart attack and stroke with Celebrex.

The regulator urged the use of alternative drugs, or a reduction in dose if a patient cannot be treated without Celebrex.

Pfizer last week said Celebrex more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.

Pfizer said doctors should be made aware of the health risks in prescribing Celebrex to their patients, but the company does not plan to recall its popular arthritis drug.

Celebrex is one of Pfizer’s biggest products, with 2003 sales of $1.9 billion. 

RELATED STORIES:
Parents too often unaware of child’s drug abuse   FDA places warning on statin labels   The Possible Dangers of Buying Medicine Online   Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers   Bayer forgot to tell risks of heart surgery drug   FDA: Power to write drug labels could help public   Doubts on suicide-anti-smoking drug Chantix link   Report says FDA not up to scratch   Prescriptions for teens and young adults on the rise   Painkiller Opana, new scourge of rural America   Drug Abuse Holds Steady In U.S.   Novo says Victoza not to blame for 2 Japan deaths

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]